Zobrazeno 1 - 10
of 111
pro vyhledávání: '"Nian Lu"'
Autor:
Hu Liang, Yao-Fei Jiang, Guo-Ying Liu, Lin Wang, Jian-Wei Wang, Nian Lu, Wei-Xiong Xia, Liang-Ru Ke, Yan-Fang Ye, Jin-Lin Duan, Wei-Xin Bei, Shu-Hui Dong, Wang-Zhong Li, Li-Ting Liu, Chong Zhao, Changqing Xie, Yan-Qun Xiang
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-8 (2024)
Abstract The antiangiogenic agent apatinib has been shown to clinically improve responses to immune checkpoint inhibitors in several cancer types. Patients with N3 nasopharyngeal carcinoma have a high risk of distant metastasis, however, if the addit
Externí odkaz:
https://doaj.org/article/a5f7d9030d814b3ca42fbfa3ef13a7ea
Autor:
Han Li, Run Lin, Yanna Zhang, Yanni Zhu, Shuting Huang, Jing Lan, Nian Lu, Chuanmiao Xie, Shanyang He, Weijing Zhang
Publikováno v:
Molecular Cancer, Vol 23, Iss 1, Pp 1-19 (2024)
Abstract Background Cisplatin (CDDP) is the first-line chemotherapeutic strategy to treat patients with ovarian cancer (OC). The development of CDDP resistance remains an unsurmountable obstacle in OC treatment and frequently induces tumor recurrence
Externí odkaz:
https://doaj.org/article/a1dd0367304b4c3db2fa89380be1e097
Autor:
Yaofei Jiang, Chun Chen, Guoying Liu, Ting Fang, Nian Lu, Weixin Bei, Shuhui Dong, Wangzhong Li, Weixiong Xia, Hu Liang, Yanqun Xiang
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract To assess the efficacy and safety of the combination of immune checkpoint inhibitors (ICIs) and target therapy (anti-angiogenesis or EGFR inhibitors) as a second-line or subsequent treatment for recurrent or metastatic nasopharyngeal carcino
Externí odkaz:
https://doaj.org/article/4d521278139c4a099bb2826984421ae5
Autor:
Yunfang Yu, Wei Ren, Zifan He, Yongjian Chen, Yujie Tan, Luhui Mao, Wenhao Ouyang, Nian Lu, Jie Ouyang, Kai Chen, Chenchen Li, Rong Zhang, Zhuo Wu, Fengxi Su, Zehua Wang, Qiugen Hu, Chuanmiao Xie, Herui Yao
Publikováno v:
Breast Cancer Research, Vol 25, Iss 1, Pp 1-14 (2023)
Abstract Background Several studies have indicated that magnetic resonance imaging radiomics can predict survival in patients with breast cancer, but the potential biological underpinning remains indistinct. Herein, we aim to develop an interpretable
Externí odkaz:
https://doaj.org/article/c411df0b8122468fbff21fe3c4fd722e
Autor:
Nian Lu, Yao-Fei Jiang, Wei-Xiong Xia, Ying Huang, Chuan-Miao Xie, Cheng Xu, Yan-Fang Ye, Guo-Ying Liu, Wei-Xin Bei, Liang-Ru Ke, Wang-Zhong Li, Cheng Zhang, Xin Wang, Qin Liu, Xi Chen, Zi-Xiong Chen, Changqing Xie, Hu Liang, Yan-Qun Xiang
Publikováno v:
EClinicalMedicine, Vol 62, Iss , Pp 102136- (2023)
Summary: Background: There are limited treatment options for patients with metastatic nasopharyngeal carcinoma (mNPC) after failure of platinum-based chemotherapy. In this trial, we assessed the efficacy and safety of sintilimab plus bevacizumab in p
Externí odkaz:
https://doaj.org/article/4ad70bdeaf304a61850080ba101bda55
Autor:
Wangzhong Li, Shuhui Lv, Guoying Liu, Nian Lu, Yaofei Jiang, Hu Liang, Weixiong Xia, Yanqun Xiang, Changqing Xie, Jianxing He
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundEpstein-Barr virus (EBV) DNA seronegative (Sero-) and seropositive (Sero+) nasopharyngeal carcinoma (NPC) are distinctly different disease subtypes. Patients with higher baseline EBV DNA titers seem to benefit less from anti-PD1 immunothera
Externí odkaz:
https://doaj.org/article/d7b445d964c54edaab5ccbe32b5ac24e
Autor:
Guo-Ying Liu, Nian Lu, Wei-Xin Bei, Wang-Zhong Li, Hu Liang, Wei-Xiong Xia, Yan-Qun Xiang, He-Rui Yao
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundWe aimed to establish a prognostic model to identify suitable candidates for chemotherapy combination PD-1 inhibitor in metastatic nasopharyngeal carcinoma (NPC) patients.Patients and methodsIn this retrospective study, we included 524 pati
Externí odkaz:
https://doaj.org/article/7f9bf4e7f50042ba8469bb5eaa7d7621
Autor:
Guo-Ying Liu, Wei-Xiong Xia, Zhuo-Fei Bi, Nian Lu, Wang-Zhong Li, Wei-Xin Bei, Hu Liang, Jun-Zhi Xie, Yi-Min Liu, He-Rui Yao, Yan-Qun Xiang
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundPlasma Epstein–Barr virus DNA (EBV-DNA) is a sensitive and specific biomarker for nasopharyngeal carcinoma (NPC). We investigated whether longitudinal monitoring of EBV-DNA could accurately detect clinical disease progression in NPC patie
Externí odkaz:
https://doaj.org/article/9526841f163241669358b77e1d5df611
Autor:
Minghao Wu, Yanyan Zhang, Jianing Zhang, Yuwei Zhang, Yina Wang, Feng Chen, Yahong Luo, Shuai He, Yulin Liu, Qian Yang, Yanying Li, Hong Wei, Hong Zhang, Nian Lu, Sicong Wang, Yan Guo, Zhaoxiang Ye, Ying Liu
Publikováno v:
Frontiers in Oncology, Vol 11 (2022)
ObjectiveBased on non-contrast-enhanced (NCE)/contrast-enhanced (CE) computed tomography (CT) images, we try to identify a combined-radiomics model and evaluate its predictive capacity regarding response to anti-PD1 immunotherapy of patients with non
Externí odkaz:
https://doaj.org/article/2ab12d354dc04366832611dea5deae86
Autor:
Yunfang Yu, Zifan He, Jie Ouyang, Yujie Tan, Yongjian Chen, Yang Gu, Luhui Mao, Wei Ren, Jue Wang, Lili Lin, Zhuo Wu, Jingwen Liu, Qiyun Ou, Qiugen Hu, Anlin Li, Kai Chen, Chenchen Li, Nian Lu, Xiaohong Li, Fengxi Su, Qiang Liu, Chuanmiao Xie, Herui Yao
Publikováno v:
EBioMedicine, Vol 69, Iss , Pp 103460- (2021)
Background: in current clinical practice, the standard evaluation for axillary lymph node (ALN) status in breast cancer has a low efficiency and is based on an invasive procedure that causes operative-associated complications in many patients. Theref
Externí odkaz:
https://doaj.org/article/b9c781378d0d4c2c8697a80f4b2f05d9